TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study

M Mitchell Emmers M Marij J. P. Welters M Michelle V. Dietz S Saskia J. Santegoets S Sanne Boekesteijn A Anouk Stolk N Nikki M. Loof D Daphne W. Dumoulin A Annemarie L. Geel L Lauri C. Steinbusch A A. Rob P. M. Valentijn D Danielle Cohen N Noel F. C. C. de Miranda E Egbert F. Smit H Hans Gelderblom T Thorbald van Hall J Joachim G. Aerts S Sjoerd H. van der Burg

Article Details

Volume / Issue Vol. 16, Issue 1
Published May 28, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (18)

M

Mitchell Emmers

M

Marij J. P. Welters

M

Michelle V. Dietz

S

Saskia J. Santegoets

S

Sanne Boekesteijn

A

Anouk Stolk

N

Nikki M. Loof

D

Daphne W. Dumoulin

A

Annemarie L. Geel

L

Lauri C. Steinbusch

A

A. Rob P. M. Valentijn

D

Danielle Cohen

N

Noel F. C. C. de Miranda

E

Egbert F. Smit

H

Hans Gelderblom

T

Thorbald van Hall

J

Joachim G. Aerts

S

Sjoerd H. van der Burg